BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 32356173)

  • 1. Fingolimod Affects Transcription of Genes Encoding Enzymes of Ceramide Metabolism in Animal Model of Alzheimer's Disease.
    Jęśko H; Wencel PL; Wójtowicz S; Strosznajder J; Lukiw WJ; Strosznajder RP
    Mol Neurobiol; 2020 Jun; 57(6):2799-2811. PubMed ID: 32356173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulatory Effects of Fingolimod (FTY720) on the Expression of Sphingolipid Metabolism-Related Genes in an Animal Model of Alzheimer's Disease.
    Jęśko H; Wencel PL; Lukiw WJ; Strosznajder RP
    Mol Neurobiol; 2019 Jan; 56(1):174-185. PubMed ID: 29687345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of Huanglian Jiedu Decoction on Microglia with Abnormal Sphingolipid Metabolism in Alzheimer's Disease.
    Qi YY; Heng X; Yao ZY; Qu SY; Ge PY; Zhao X; Ni SJ; Guo R; Yang NY; Zhang QC; Zhu HX
    Drug Des Devel Ther; 2022; 16():931-950. PubMed ID: 35391788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Inflammatory Treatment with FTY720 Starting after Onset of Symptoms Reverses Synaptic Deficits in an AD Mouse Model.
    Kartalou GI; Salgueiro-Pereira AR; Endres T; Lesnikova A; Casarotto P; Pousinha P; Delanoe K; Edelmann E; Castrén E; Gottmann K; Marie H; Lessmann V
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Ceramidases in Sphingolipid Metabolism and Human Diseases.
    Parveen F; Bender D; Law SH; Mishra VK; Chen CC; Ke LY
    Cells; 2019 Dec; 8(12):. PubMed ID: 31817238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Ceramide Synthase 6 Transcriptionally Activates Acid Ceramidase in a c-Jun N-terminal Kinase (JNK)-dependent Manner.
    Tirodkar TS; Lu P; Bai A; Scheffel MJ; Gencer S; Garrett-Mayer E; Bielawska A; Ogretmen B; Voelkel-Johnson C
    J Biol Chem; 2015 May; 290(21):13157-67. PubMed ID: 25839235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FTY720 decreases ceramides levels in the brain and prevents memory impairments in a mouse model of familial Alzheimer's disease expressing APOE4.
    Crivelli SM; Luo Q; Kruining DV; Giovagnoni C; Mané-Damas M; den Hoedt S; Berkes D; De Vries HE; Mulder MT; Walter J; Waelkens E; Derua R; Swinnen JV; Dehairs J; Wijnands EPM; Bieberich E; Losen M; Martinez-Martinez P
    Biomed Pharmacother; 2022 Aug; 152():113240. PubMed ID: 35689862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of sphingolipid turnover and chronic generation of ceramide and sphingosine in liver during aging.
    Lightle SA; Oakley JI; Nikolova-Karakashian MN
    Mech Ageing Dev; 2000 Dec; 120(1-3):111-25. PubMed ID: 11087909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulation of sphingolipid metabolism in Alzheimer's disease.
    He X; Huang Y; Li B; Gong CX; Schuchman EH
    Neurobiol Aging; 2010 Mar; 31(3):398-408. PubMed ID: 18547682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial Effects of Fingolimod in Alzheimer's Disease: Molecular Mechanisms and Therapeutic Potential.
    Angelopoulou E; Piperi C
    Neuromolecular Med; 2019 Sep; 21(3):227-238. PubMed ID: 31313064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Human and Mouse Spino-Cerebellar Tissue, Ataxin-2 Expansion Affects Ceramide-Sphingomyelin Metabolism.
    Sen NE; Arsovic A; Meierhofer D; Brodesser S; Oberschmidt C; Canet-Pons J; Kaya ZE; Halbach MV; Gispert S; Sandhoff K; Auburger G
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31766565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Quercetin and Fingolimod, Alone or in Combination, on the Sphingolipid Metabolism in HepG2 Cells.
    Momchilova A; Nikolaev G; Pankov S; Vassileva E; Krastev N; Robev B; Krastev D; Pinkas A; Pankov R
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Ceramide-Metabolizing Enzymes in the Heart Adipose Tissue of Cardiovascular Disease Patients.
    Gruzdeva O; Dyleva Y; Belik E; Uchasova E; Ponasenko A; Ivanov S; Zinets M; Stasev A; Kutikhin A; Markova V; Poddubnyak A; Gorbatovskaya E; Fanaskova E; Barbarash O
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of ceramide and sphingolipid metabolism in tumors: potential modulation of chemotherapy.
    Modrak DE
    Methods Mol Med; 2005; 111():183-94. PubMed ID: 15911980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease?
    Katsel P; Li C; Haroutunian V
    Neurochem Res; 2007; 32(4-5):845-56. PubMed ID: 17342407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate.
    Laviad EL; Albee L; Pankova-Kholmyansky I; Epstein S; Park H; Merrill AH; Futerman AH
    J Biol Chem; 2008 Feb; 283(9):5677-84. PubMed ID: 18165233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of ceramide and SEW 2871 in the transcription of enzymes involved in amyloid b precursor protein metabolism in an experimental model of Alzheimer's disease.
    Czubowicz K; Wójtowicz S; Wencel PL; Strosznajder RP
    Folia Neuropathol; 2018; 56(3):196-205. PubMed ID: 30509041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD Mouse.
    Dinkins MB; Enasko J; Hernandez C; Wang G; Kong J; Helwa I; Liu Y; Terry AV; Bieberich E
    J Neurosci; 2016 Aug; 36(33):8653-67. PubMed ID: 27535912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of ceramide and sphingosine 1-phosphate on ERM phosphorylation: probing sphingolipid signaling at the outer plasma membrane.
    Canals D; Jenkins RW; Roddy P; Hernández-Corbacho MJ; Obeid LM; Hannun YA
    J Biol Chem; 2010 Oct; 285(42):32476-85. PubMed ID: 20679347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-Related Transcriptional Deregulation of Genes Coding Synaptic Proteins in Alzheimer's Disease Murine Model: Potential Neuroprotective Effect of Fingolimod.
    Jęśko H; Wieczorek I; Wencel PL; Gąssowska-Dobrowolska M; Lukiw WJ; Strosznajder RP
    Front Mol Neurosci; 2021; 14():660104. PubMed ID: 34305524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.